Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BalchemFRA:BL9B +4.06%93 5-Year Yield-on-Cost % is 1.00 as of Jul. 29, 2026, which is 20% above its 10-year median of 0.83. GuruFocus rates FRA:BL9B with a GF Score™ of 93/100 and a GF Value™ of €149.73 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,057 Chemicals companies, Balchem ranks worse than 66.32% on this metric.
Balchem's yield on cost for the quarter that ended in Mar. 2026 was 1.00.
The historical rank and industry rank for Balchem's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:BL9B'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.58 Med: 0.83 Max: 1.03
Current: 1
During the past 13 years, Balchem's highest Yield on Cost was 1.03. The lowest was 0.58. And the median was 0.83.
FRA:BL9B's 5-Year Yield-on-Cost % is ranked worse than 66.32% of 1057
companies
in the Chemicals industry
Industry Median: 1.85
vs FRA:BL9B: 1.00
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Balchem 5-Year Yield-on-Cost % Related Terms
FRA:BL9B vs SXT, PRM, CBT: 5-Year Yield-on-Cost % Comparison
For the Specialty Chemicals subindustry, Balchem's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balchem 5-Year Yield-on-Cost % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balchem's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Balchem's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Balchem is calculated as
Balchem (FRA:BL9B) has a 5-Year Yield-on-Cost % of 1.00 as of Jul. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Balchem and its competitors. This is 20% above median its historical median of 0.83. Over the past decade, Balchem's 5-Year Yield-on-Cost % has ranged from 0.58 to 1.03. According to the industry distribution chart, Balchem ranks #701 out of 1057 companies in the Chemicals industry, placing it in the top 66.3%.
Is Balchem's 5-Year Yield-on-Cost % too high?
Balchem's current 5-Year Yield-on-Cost % of 1.00 is 20% above median its 10-year median of 0.83. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 1.03. The Chemicals industry median 5-Year Yield-on-Cost % is 1.85. Balchem's value of 1.00 is 45.9% below this industry median. Based on the distribution chart, Balchem ranks #701 out of 1057 companies in the Chemicals industry, which is below the industry midpoint. Overall, Balchem has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's 5-Year Yield-on-Cost % compare to SXT and PRM?
According to the Chemicals industry distribution chart, Balchem ranks #701 out of 1057 companies for 5-Year Yield-on-Cost %. This places Balchem in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.85. Balchem's value of 1.00 is 45.9% below this benchmark. Historically, Balchem's own 5-Year Yield-on-Cost % has ranged from 0.58 to 1.03 over the past decade. While the company's 10-year median is 0.83 vs. the industry median of 1.85, Balchem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Chemicals company?
The median 5-Year Yield-on-Cost % among Chemicals companies is 1.85, based on 1,057 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balchem's current 5-Year Yield-on-Cost % of 1.00 is 45.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Balchem and its competitors. For the Chemicals industry, the median 5-Year Yield-on-Cost % is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balchem's current 5-Year Yield-on-Cost % is 1.00, which is 20% above median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (FRA:BL9B) is currently considered Fairly Valued. The stock's GF Value™ is €149.73, compared to a current price of €143.70 — trading 4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.00, which is 20% above median its 10-year median of 0.83 and 45.9% below the Chemicals industry median of 1.85. Balchem's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Balchem (FRA:BL9B), the current 5-Year Yield-on-Cost % is 1.00 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balchem (FRA:BL9B) Overvalued in 2026?
Based on GuruFocus' analysis, Balchem stock appears to be undervalued.
The current stock price of €143.70 is trading 4% below its estimated GF Value™ of €149.73.
GuruFocus considers Balchem to be Fairly Valued.
Key valuation signals for FRA:BL9B:
5-Year Yield-on-Cost %: 1.00 (20% above median its 10-year median of 0.83)
GF Value™: €149.73 vs. price of €143.70 (4% below fair value)
Industry Position: 45.9% below the Chemicals median (#701 of 1057)
No single metric tells the full story. See the FRA:BL9B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
93GF Score
Get the complete analysis for FRA:BL9B
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BL9B has been successfully added to your 
